CRISPR —Clustered Regularly Interspaced Short Palindromic Repeats– (CRISPR)– is a groundbreaking addition to the tech industry. This new gene editing technology actually was discovered in E. coli, a form of bacteria, and realized the commonality of this gene editor. Scientists have seen CRISPR in action when it developed cancer immunotherapies, disease resistant crops, and healthier livestock. This new era of medicine provides treatment for a patient’s life, titled In Vivo, clearing out Lp(a), ANGPTL3, while aiming to treat cancer together.

 An informational study by the organization NHGRI states, “When I first learned about CRISPR about a decade ago, the technology and the future possibilities were just amazing. A few years after that, I had the joy of meeting Dr. Jennifer Doudna at a small meeting at NHGRI, and we knew at that time that we were talking to a future Nobel Prize winner and, indeed, she got that very recently.”

According to Synthego, a gene product company mentions “the CRISPR revolution and its potential impact on global health security increasing number of biotech startup companies focusing on CRISPR-Cas9 gene editing technology, and many researchers are continually finding new ways of applying this technology to solve real-world problems”

Gene editing might have its pros and cons, but it will start to serve the new generation of gene editing, towards a future unimaginable.